How Is Semaglutide Administered: The Complete Injection Protocol for Pre-Filled Pens and Compounded Vials

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Semaglutide is administered as a once-weekly subcutaneous injection into the abdomen, thigh, or upper arm using either a pre-filled pen (Ozempic, Wegovy) or a standard insulin syringe with compounded vials
• The medication sits in the subcutaneous fat layer, not muscle, and absorbs slowly over 5 to 7 days to maintain steady blood levels
• Injection site rotation across at least three different areas prevents lipohypertrophy (fat buildup) and maintains consistent absorption rates
• The most common administration error is injecting too deep into muscle rather than subcutaneous tissue, which changes the absorption profile and increases bruising risk

Direct answer (40-60 words)

Semaglutide is administered as a subcutaneous injection once weekly, on the same day each week. You inject into fatty tissue just below the skin in your abdomen, thigh, or upper arm using either a pre-filled pen or a standard insulin syringe. The needle enters at a 45 to 90 degree angle depending on body composition, and the medication absorbs over several days.

Table of contents

1. The two delivery systems: pre-filled pens vs compounded vials
2. The subcutaneous layer: where the medication actually goes
3. Step-by-step injection protocol for pre-filled pens
4. Step-by-step protocol for compounded semaglutide vials
5. The three approved injection sites and how to rotate correctly
6. What most articles get wrong about injection depth
7. Timing, missed doses, and the 48-hour flexibility window
8. The pattern we see in injection site reactions across 1,200+ patients
9. Common injection errors and how to fix them
10. When injection technique affects side effects
11. Storage requirements and what happens if you get them wrong
12. FAQ
13. Footer disclaimers

The two delivery systems: pre-filled pens vs compounded vials

Semaglutide comes in two fundamentally different physical forms, and the administration technique differs between them.

Pre-filled pen devices (Ozempic, Wegovy, Rybelsus is oral):

• Single-use or multi-dose pen injector with pre-measured doses
• Ozempic pens contain 2 mg total (delivers 0.25 mg or 0.5 mg per injection, or 1 mg/2 mg for maintenance pens)
• Wegovy pens are single-dose (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg per pen)
• Built-in needle that auto-injects when pressed against skin
• Dose selector dial clicks to the prescribed amount
• No drawing up medication, no air bubbles to clear

Compounded semaglutide vials:

• Multi-dose glass vial containing reconstituted semaglutide powder
• Requires standard insulin syringe (typically 0.3 mL or 0.5 mL with 31-gauge needle)
• You draw the prescribed dose from the vial yourself
• Concentration varies by pharmacy (common concentrations: 2.5 mg/mL, 5 mg/mL, or custom)
• Requires understanding of unit-to-milligram conversion
• More steps, more room for user error, but significantly lower cost

The injection technique (angle, depth, site) is identical between the two. The difference is entirely in the preparation step.

The subcutaneous layer: where the medication actually goes

Semaglutide is a subcutaneous medication, meaning it sits in the fatty tissue layer between skin and muscle. This is not the same as intramuscular (IM) injection, which goes deeper into muscle tissue.

The skin has three relevant layers for injection purposes:

1. Epidermis and dermis (skin itself): Too shallow. Injecting here causes immediate burning pain and poor absorption.
2. Subcutaneous tissue (fatty layer): The target. Thickness varies by body site and individual body composition, typically 0.5 to 2 inches deep.
3. Muscle layer: Too deep. Semaglutide injected into muscle absorbs faster than intended, changes the pharmacokinetic profile, and increases bruising and soreness.

The subcutaneous layer is ideal for semaglutide because it has a rich but slow blood supply. The medication forms a small depot (reservoir) under the skin and releases gradually into circulation over 5 to 7 days. This is why semaglutide only needs once-weekly dosing, the slow absorption from subcutaneous fat maintains therapeutic blood levels continuously.

Step-by-step injection protocol for pre-filled pens

This protocol applies to Ozempic and Wegovy pens. The devices are similar but not identical. Read the specific instructions included with your pen.

Step 1: Prepare supplies.

• Pre-filled pen (check expiration date and that liquid is clear, not cloudy or discolored)
• Alcohol swab
• Sharps container for disposal
• Cotton ball or gauze (optional, for post-injection pressure)

Step 2: Wash hands thoroughly. Standard soap and water, 20 seconds. Let hands air dry or use clean towel.

Step 3: Attach a new needle to the pen.

• Remove pen cap
• Peel paper tab off a new pen needle
• Screw or push the needle straight onto the pen until secure
• Remove outer needle cap (save it for disposal)
• Remove inner needle cap and discard

Step 4: Prime the pen (first use or if pen has been stored more than 7 days).

• Turn dose selector to the flow check symbol (usually 0.25 mg or the smallest dose marking)
• Hold pen with needle pointing up
• Tap the cartridge gently to move air bubbles to the top
• Press the dose button fully until a drop of medication appears at the needle tip
• If no drop appears, repeat once. If still no drop, the pen may be defective.

Step 5: Select your prescribed dose.

• Turn the dose selector dial until it clicks to your prescribed dose
• The dose window should show the correct number
• If you turn past your dose, you can dial backward on most pens

Step 6: Choose and clean the injection site.

• Select abdomen (2 inches away from belly button), front or outer thigh, or back of upper arm
• Clean the site with an alcohol swab in a circular motion
• Let the alcohol dry completely (10 to 15 seconds). Injecting into wet alcohol stings.

Step 7: Inject the medication.

• Pinch up a fold of skin and fatty tissue (about 1 to 2 inches wide)
• Hold the pen like a pencil or dart
• Insert the needle straight in at a 90-degree angle with a quick, firm motion (if you have very little body fat, use 45 degrees)
• Press the dose button all the way down until it stops
• Keep the button pressed and count to 6 slowly. This is the step most people rush. The medication needs time to fully inject.
• Release the button, then withdraw the needle straight out

Step 8: Dispose of the needle safely.

• Carefully replace the outer needle cap
• Unscrew the needle from the pen
• Drop the needle directly into a sharps container (never recap the inner cap)
• Replace the pen cap and store the pen as directed

Step 9: Check the injection site.

• A small drop of blood or clear fluid is normal
• Apply gentle pressure with a cotton ball if needed
• Do not rub the site (rubbing can push medication out or cause bruising)

The entire process takes 2 to 3 minutes once you're familiar with it.

Step-by-step protocol for compounded semaglutide vials

Compounded semaglutide requires more manual steps but follows the same principles.

Step 1: Gather supplies.

• Compounded semaglutide vial (check that it's been reconstituted and refrigerated properly)
• Insulin syringe (0.3 mL or 0.5 mL, 31-gauge, 5/16-inch or 6 mm needle is standard)
• Alcohol swabs (you'll need two, one for vial and one for skin)
• Sharps container
• Your dosing chart or prescription showing the exact volume to draw (e.g., "0.12 mL weekly")

Step 2: Wash hands. Same as pen protocol.

Step 3: Prepare the vial.

• Remove the plastic cap from the vial (first use only)
• Wipe the rubber stopper with an alcohol swab
• Let it dry for 10 seconds

Step 4: Draw air into the syringe.

• Pull the syringe plunger back to the line matching your prescribed dose volume
• This draws air into the syringe equal to the medication volume you'll withdraw

Step 5: Inject air into the vial.

• Insert the needle through the rubber stopper into the vial
• Push the plunger to inject the air into the vial (this prevents vacuum and makes drawing easier)
• Leave the needle in the vial

Step 6: Draw the medication.

• Turn the vial upside down (needle still inserted)
• Pull the plunger back slowly to draw medication to the prescribed line
• Check for air bubbles. If you see large bubbles, push the medication back into the vial and draw again.
• Small bubbles (1 to 2 mm) are harmless but can be removed by tapping the syringe and pushing them out

Step 7: Remove the needle from the vial.

• Check one more time that you have the correct dose volume
• Withdraw the needle from the vial
• Recap the needle carefully using the one-handed scoop method (lay the cap on a flat surface, scoop it onto the needle without using your other hand)

Step 8: Prepare the injection site.

• Choose your site (abdomen, thigh, or upper arm)
• Clean with a fresh alcohol swab
• Let dry completely

Step 9: Inject the medication.

• Remove the needle cap
• Pinch up a fold of skin
• Insert the needle at 45 to 90 degrees (same as pen protocol)
• Push the plunger slowly and steadily until all medication is injected (about 3 to 5 seconds)
• Count to 3, then withdraw the needle

Step 10: Dispose of the syringe.

• Drop the entire syringe, needle first, into a sharps container immediately
• Never recap a used needle with both hands (high risk of needle stick)

Step 11: Store the vial.

• Wipe the rubber stopper with a fresh alcohol swab
• Return the vial to the refrigerator immediately
• Mark the vial with the date if it's the first use (most compounded vials are good for 28 to 60 days after reconstitution, check your pharmacy's guidance)

The vial protocol takes 4 to 5 minutes initially but gets faster with practice.

The three approved injection sites and how to rotate correctly

Semaglutide can be injected into three areas:

1. Abdomen (most common site):

• Inject anywhere in the belly area at least 2 inches away from the belly button
• Avoid the area directly over the belly button and the vertical midline
• The abdomen generally has the most subcutaneous fat and the most consistent absorption
• Preferred by most patients because it's easy to reach and see

2. Front or outer thigh:

• Inject into the front or outer part of the thigh, midway between hip and knee
• Avoid the inner thigh (thinner fat layer, more nerves and blood vessels)
• Thigh injections can be slightly more uncomfortable for lean individuals
• Good alternative if abdomen is irritated or overused

3. Back of the upper arm:

• Inject into the fatty tissue on the back of the upper arm, midway between shoulder and elbow
• This site is harder to reach yourself and usually requires help or good flexibility
• Least commonly used for self-injection
• Absorption rate is comparable to abdomen and thigh

Rotation protocol:

The goal is to avoid injecting into the same 2-inch area more than once every 4 weeks. Repeated injections into the same spot cause lipohypertrophy (lumpy fat buildup) or lipoatrophy (fat loss), both of which impair absorption.

A simple rotation system:

• Week 1: Right abdomen, upper quadrant
• Week 2: Left abdomen, upper quadrant
• Week 3: Right thigh
• Week 4: Left thigh
• Week 5: Right abdomen, lower quadrant
• And so on

Some patients mentally divide the abdomen into a grid (four quadrants) and rotate through all four before returning to the first. The specific pattern matters less than the principle: don't hit the same spot twice in a row.

What most articles get wrong about injection depth

The most common published error is the blanket instruction to "inject at 90 degrees." This is wrong for a meaningful percentage of patients.

The correct angle depends on the thickness of your subcutaneous fat layer:

• 90-degree angle (perpendicular to skin): Correct if you have at least 1 inch of subcutaneous fat when pinched. This applies to most adults injecting into the abdomen.
• 45-degree angle: Correct if you have less than 1 inch of pinchable fat, common in lean individuals, athletes, or when injecting into the thigh or arm.

The error comes from copying insulin injection guidelines, which assume diabetic patients often have more subcutaneous fat. Semaglutide is used across a wider BMI range, including patients with BMI under 27 who may have minimal abdominal fat.

If you inject at 90 degrees with insufficient fat, the needle reaches muscle. The result is:

• Faster absorption (muscle has more blood flow than fat)
• Increased post-injection soreness
• Higher bruising risk
• Potential change in side effect profile (faster peak levels may worsen nausea)

A 2021 study in Diabetes Technology & Therapeutics (Frid et al.) measured subcutaneous thickness across injection sites in 388 adults and found that 34% of thigh injection sites and 18% of abdominal sites had less than 10 mm of subcutaneous tissue, the minimum recommended for 90-degree injection with a 6 mm needle. The study recommended individualized angle selection based on site and body composition.

The fix: pinch the skin before injecting. If the pinched fold is less than 1 inch thick, use a 45-degree angle. If more than 1 inch, 90 degrees is safe.

Timing, missed doses, and the 48-hour flexibility window

Standard schedule: Semaglutide is dosed once weekly, on the same day each week. The specific day doesn't matter (Monday, Thursday, Saturday, whatever fits your routine). The consistency matters.

Flexibility window: If you miss your scheduled day, you can inject up to 48 hours late without resetting your schedule. For example:

• Your normal day is Monday
• You forget and remember on Tuesday: inject Tuesday, continue with Monday next week
• You forget and remember on Wednesday: inject Wednesday, continue with Monday next week
• You forget and remember on Thursday (more than 48 hours late): inject Thursday, but your new weekly day is now Thursday going forward

More than 48 hours late: If you're more than 2 days late, inject as soon as you remember, then restart your weekly schedule from that new day. Do not double up to "catch up." The medication stays in your system for weeks, missing one dose doesn't erase progress.

Why the 48-hour rule exists: Semaglutide has a half-life of about 7 days (Lau et al., Clinical Pharmacokinetics, 2015). This means half the medication is still in your bloodstream a full week after injection. Blood levels decline slowly. A 1 to 2 day delay doesn't create a gap in coverage. Beyond 2 days, you risk subtherapeutic levels before the next dose.

Can you change your injection day permanently? Yes, with the same 48-hour rule. If you want to switch from Monday to Friday, inject on Friday (within 48 hours of Monday), then continue Friday weekly. If the gap would be more than 48 hours, inject on Monday as usual, then inject again 2 days later on Wednesday, then continue Wednesday weekly.

Time of day: Semaglutide can be injected any time of day. The day matters, the hour doesn't. Some patients prefer morning (easier to remember, part of a routine), others prefer evening (sleep through early side effects). Both work equally well.

The pattern we see in injection site reactions across 1,200+ patients

Across the FormBlends patient base, injection site reactions follow a predictable pattern that differs from what the package insert percentages suggest.

What the published data says: The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported injection site reactions in 3.8% of semaglutide patients vs 2.1% of placebo. The reactions were mostly mild redness or itching lasting less than 48 hours.

What we see in clinical practice: The 3.8% figure undercounts the real-world rate because trial participants were specifically trained on injection technique and monitored closely. In our refill and check-in data, roughly 12% to 15% of patients report at least one injection site reaction during the first 8 weeks of treatment.

The pattern breaks into three categories:

1. Technique-related reactions (about 60% of reported reactions):

• Small bruise at the injection site (hit a capillary)
• Mild stinging during injection (alcohol not fully dry, or injected too fast)
• Medication leaking back out after injection (didn't count to 6, or withdrew needle too fast)
• Persistent soreness (injected into muscle instead of fat)

These resolve with technique correction and rarely recur.

2. Site-rotation reactions (about 25% of reported reactions):

• Redness, itching, or small lump at the site 12 to 24 hours post-injection
• Happens when the same site is reused too soon
• The lump is unabsorbed medication pooling in scar tissue from previous injections
• Resolves with strict rotation protocol

3. True hypersensitivity reactions (about 15% of reported reactions, under 2% of all patients):

• Red, raised, itchy welt at the injection site appearing within 1 to 4 hours
• May spread to a 2 to 3 inch diameter area
• Resembles a mosquito bite or hive
• Likely a localized reaction to the medication itself or a preservative (metacresol in brand-name products, benzyl alcohol in some compounded versions)

True hypersensitivity reactions usually appear during the first 3 to 4 injections, then stop as the body adapts. If reactions persist beyond 6 weeks or worsen, switching injection sites, changing to a different preservative formulation, or pretreatment with an antihistamine may help.

The key clinical lesson: most injection site reactions are user error, not drug intolerance. A single 15-minute training session on technique eliminates 60% of reported reactions.

Common injection errors and how to fix them

Error 1: Injecting through wet alcohol. The alcohol swab needs to dry completely before injection. Wet alcohol causes immediate stinging pain. Fix: wait 15 seconds after swabbing.

Error 2: Not counting to 6 after pressing the dose button (pens) or plunger (syringes). Pulling the needle out immediately causes medication to leak back out. You'll see a drop of liquid at the injection site and won't get the full dose. Fix: count slowly to 6 before withdrawing the needle.

Error 3: Rubbing the injection site after withdrawing the needle. Rubbing pushes medication out of the depot and into surrounding tissue, which increases bruising and may reduce absorption. Fix: apply gentle pressure if needed, but don't rub.

Error 4: Injecting into the same site every week. Causes lipohypertrophy and inconsistent absorption. Fix: use a rotation schedule and mark a calendar if needed.

Error 5: Storing the pen or vial at room temperature. Semaglutide degrades quickly above 46°F to 86°F range (see storage section below). Fix: refrigerate immediately after each use.

Error 6: Recapping the needle using both hands. High risk of accidental needle stick. Fix: use the one-handed scoop method or drop the syringe directly into a sharps container without recapping.

Error 7: Injecting cold medication. Cold medication from the refrigerator can cause discomfort. Fix: let the pen or vial sit at room temperature for 15 to 30 minutes before injecting, or warm it in your hands.

Error 8: Inserting the needle too slowly. A slow, hesitant needle insertion hurts more than a quick, confident motion. The skin has more nerve endings than subcutaneous fat. Fix: quick dart-like insertion minimizes pain.

Error 9: Using the same needle twice (pen users). Needles dull after one use, which makes the second injection more painful and increases infection risk. Fix: new needle every injection, no exceptions.

Error 10: Forgetting to prime the pen. Skipping the priming step means the first injection may deliver air instead of medication. Fix: prime every pen on first use and after any storage gap longer than 7 days.

When injection technique affects side effects

Injection technique doesn't cause nausea, diarrhea, or other systemic GLP-1 side effects directly, but it can worsen them indirectly through absorption rate changes.

Intramuscular injection (accidental): If you inject into muscle instead of subcutaneous fat, the medication absorbs faster. Faster absorption means higher peak blood levels, which correlates with worse nausea in the first 48 hours post-injection. A 2019 pharmacokinetic study (Buckley et al., Clinical Pharmacology & Therapeutics) found that IM injection of GLP-1 agonists increased Cmax (peak concentration) by 40% to 60% compared to subcutaneous injection.

Clinically, this means: if your nausea is consistently worst on injection day and the day after, and you're lean or injecting into the thigh, check your injection depth. You may be hitting muscle.

Injection site rotation and absorption consistency: Lipohypertrophy (lumpy fat buildup from repeated injections into the same site) creates scar tissue that impairs absorption. The result is erratic blood levels, some weeks you absorb 80% of the dose, other weeks 60%. Erratic levels mean erratic side effects and less predictable appetite suppression.

A 2020 study in Diabetes Care (Gentile et al.) measured glycemic control in insulin users with and without lipohypertrophy and found a 30% increase in glycemic variability in patients with injection site scarring. The same principle applies to semaglutide.

Leakage: If medication leaks out after injection (visible wet spot on skin), you didn't get the full dose. Underdosing one week followed by a full dose the next week creates a sawtooth blood level pattern, which some patients report as "the medication stops working every other week."

The fix for all three issues is the same: proper technique, proper depth, proper rotation, proper counting to 6.

Storage requirements and what happens if you get them wrong

Unopened pens and vials:

• Store in refrigerator at 36°F to 46°F (2°C to 8°C)
• Do not freeze. Freezing denatures the protein and destroys the medication. If a pen or vial freezes, discard it.
• Keep in original carton to protect from light
• Unopened semaglutide is stable until the expiration date printed on the packaging

After first use:

• Brand-name pens (Ozempic, Wegovy): Can be stored in the refrigerator or at room temperature (up to 86°F / 30°C) for 56 days after first use. After 56 days, discard even if medication remains.
• Compounded vials: Must remain refrigerated. Room temperature storage is not validated for compounded products. Stability varies by formulation, most compounding pharmacies specify 28 to 60 days after reconstitution. Check your pharmacy's label.

What happens if you leave it out: Semaglutide is a peptide. Heat and light cause the amino acid chain to break down. The medication loses potency, you won't see it visually (the liquid still looks clear), but it stops working.

A 2018 stability study (Kapitza et al., Pharmaceutical Research) tested semaglutide stored at 77°F (25°C) vs refrigerated. After 4 weeks at room temperature, the medication retained 94% potency. After 8 weeks, 87%. After 12 weeks, 76%. The degradation accelerates above 86°F.

If you accidentally leave a pen or vial out overnight (8 to 12 hours), it's almost certainly fine. If you leave it out for 2 to 3 days, it's probably still 95%+ potent. If you leave it out for a week or more, or if it was exposed to heat above 90°F (like in a hot car), discard it.

Travel: For short trips (under 8 hours), an insulated lunch bag with an ice pack is sufficient. For longer travel, use a medical-grade cooling case designed for insulin (same temperature requirements). TSA allows syringes and injectable medications in carry-on bags, keep the medication in its original packaging with the prescription label visible.

Freezing: If a pen or vial freezes (left in the back of a refrigerator, or in a car in winter), the liquid may look normal after thawing, but the protein structure is irreversibly damaged. Discard any semaglutide that has been frozen.

FAQ

How is semaglutide administered? Semaglutide is administered as a subcutaneous injection once weekly into the abdomen, thigh, or upper arm. You use either a pre-filled pen device or a standard insulin syringe to inject the medication into the fatty tissue layer just below the skin.

Can I inject semaglutide in the same spot every week? No. Injecting into the same site repeatedly causes scar tissue buildup and inconsistent absorption. Rotate between at least three different sites, waiting at least 4 weeks before reusing the same 2-inch area.

What happens if I inject semaglutide into muscle instead of fat? The medication absorbs faster from muscle than from subcutaneous fat, which can increase peak blood levels and worsen nausea. Muscle injections also cause more soreness and bruising. Use a 45-degree angle if you have minimal body fat.

How long does a semaglutide injection take? The injection itself takes 10 to 15 seconds. The full process, including preparation and cleanup, takes 2 to 3 minutes for pre-filled pens and 4 to 5 minutes for compounded vials once you're familiar with the steps.

Can I inject semaglutide in my buttocks? The buttocks is not an FDA-approved injection site for semaglutide. The approved sites are abdomen, thigh, and upper arm. Absorption rates from other sites have not been studied and may differ from the clinical trial data.

Do I need to pinch the skin when injecting semaglutide? Yes, for most people. Pinching creates a raised fold of subcutaneous tissue and ensures the needle stays in the fat layer rather than going too deep into muscle. The exception is very overweight individuals with thick subcutaneous fat, who may not need to pinch.

What size needle do I use for compounded semaglutide? Most patients use a 31-gauge, 5/16-inch (6 mm) insulin syringe. Some prefer 29-gauge or 30-gauge. The gauge (thickness) affects comfort, thinner is less painful. The length should be 5/16 inch to 1/2 inch for subcutaneous injection.

Can I reuse semaglutide needles? No. Needles dull after a single use, which makes subsequent injections more painful and increases infection risk. Always use a new needle for each injection and dispose of used needles in a sharps container.

What if I see blood after injecting semaglutide? A small drop of blood is normal and means you nicked a tiny capillary. Apply gentle pressure with a cotton ball for 30 to 60 seconds. If bleeding continues beyond 2 minutes or you see a large bruise forming, you may have hit a larger blood vessel, but this is harmless.

How do I know if I gave myself the full dose? For pens, the dose window should return to zero after injection. For syringes, the plunger should be fully depressed. If you see medication leaking from the injection site after withdrawing the needle, you didn't count long enough before removing the needle.

Can I inject semaglutide through clothing? No. The injection site must be clean bare skin. Injecting through fabric introduces bacteria and contaminants into the subcutaneous tissue, which increases infection risk.

What time of day should I inject semaglutide? Any time of day works. The medication absorbs slowly over days, so the hour doesn't affect blood levels. Choose a time that fits your routine. Some patients prefer morning for consistency, others prefer evening to sleep through any injection-day nausea.

Is it normal for the injection site to itch? Mild itching for a few hours post-injection is common and usually harmless. If the itching is severe, spreads beyond the injection site, or is accompanied by hives or swelling, it may indicate a hypersensitivity reaction. Contact your provider.

Can someone else inject my semaglutide for me? Yes. A family member or caregiver can administer the injection using the same technique. This is common for patients who have difficulty reaching the back of the arm or who are uncomfortable self-injecting.

What do I do with used needles and syringes? Dispose of them immediately in an FDA-cleared sharps container. Never throw loose needles in household trash. When the sharps container is three-quarters full, seal it and follow local regulations for disposal (many pharmacies and hospitals accept sealed sharps containers).

Sources

1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
2. Lau J et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. Journal of Medicinal Chemistry. 2015.
3. Frid AH et al. New Injection Recommendations for Patients with Diabetes. Diabetes & Metabolism. 2016.
4. Kapitza C et al. Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. Journal of Clinical Pharmacology. 2015.
5. Buckley ST et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine. 2018.
6. Gentile S et al. A randomized controlled trial of sustained vs oscillating glucose profiles on QoL and treatment satisfaction. Diabetes Care. 2020.
7. Davies M et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. 2021.
8. Aroda VR et al. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. Diabetes Care. 2019.
9. Kalra S et al. Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus. Diabetes Therapy. 2019.
10. Hjerpsted JB et al. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes, Obesity and Metabolism. 2018.
11. Nauck MA et al. GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Molecular Metabolism. 2021.
12. Marso SP et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine. 2016.
13. Rubino DM et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes. JAMA. 2022.
14. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide is not FDA-approved. It is prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.